Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients
Sci Rep
.
2021 Jul 7;11(1):14400.
doi: 10.1038/s41598-021-93187-8.
Authors
Toshinori Murata
1
,
Mineo Kondo
2
,
Makoto Inoue
3
,
Shintaro Nakao
4
,
Rie Osaka
5
,
Chieko Shiragami
5
,
Kenji Sogawa
6
,
Akikazu Mochizuki
7
,
Rumiko Shiraga
7
,
Yohei Ohashi
7
,
Takeumi Kaneko
7
,
Chikatapu Chandrasekhar
8
,
Akitaka Tsujikawa
9
,
Motohiro Kamei
10
Affiliations
1
Department of Ophthalmology, Shinshu University School of Medicine, 3‑1‑1 Asahi, Matsumoto, Nagano, Japan. murata@shinshu-u.ac.jp.
2
Department of Ophthalmology, Mie University Graduate School of Medicine, Mie, Japan.
3
Department of Ophthalmology, Kyorin Eye Center, Kyorin University School of Medicine, Tokyo, Japan.
4
Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
5
Department of Ophthalmology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
6
Department of Ophthalmology, Asahikawa Medical University, Hokkaido, Japan.
7
Novartis Pharma K.K., Tokyo, Japan.
8
Novartis Healthcare Pvt. Ltd., Hyderabad, India.
9
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
10
Department of Ophthalmology, Aichi Medical University, Aichi, Japan.
PMID:
34234192
PMCID:
PMC8263590
DOI:
10.1038/s41598-021-93187-8
No abstract available
Publication types
Published Erratum